Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Kohl's
KSS
$2.03B
| $750K | ﹤0.01% |
11,981
-280,096
| -96% | -$19.4M |
|
|
GCAP
2402
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $749K | ﹤0.01% |
78,355
-77,773
| -50% | -$763K |
|
|
TNAV
2403
DELISTED
Telenav Inc.
TNAV
| $748K | ﹤0.01% |
92,953
+73,079
| +368% | +$633K |
|
|
RELY
2404
DELISTED
Real Industry, Inc.
RELY
| $748K | ﹤0.01% |
+65,874
| New | +$684K |
|
2405
Barrett Business Services
BBSI
$823M
| $746K | ﹤0.01% |
82,116
-381,484
| -82% | -$3.85M |
|
2406
EXL Service
EXLS
$5.69B
| $746K | ﹤0.01% |
107,905
-268,180
| -71% | -$1.86M |
|
|
NEWR
2407
DELISTED
New Relic, Inc.
NEWR
| $746K | ﹤0.01% |
+21,193
| New | +$692K |
|
2408
CALL
Freeport-McMoran
FCX
$113B
| $745K | ﹤0.01% |
40,000
-50,100
| -56% | -$1.03M |
|
|
NATI
2409
DELISTED
National Instruments Corp
NATI
| $744K | ﹤0.01% |
25,257
-293,919
| -92% | -$9.04M |
|
|
NFBK
2410
DELISTED
Northfield Bancorp
NFBK
| $743K | ﹤0.01% |
+49,384
| New | +$729K |
|
|
OKSB
2411
DELISTED
Southwest Bancorp Inc/OK
OKSB
| $743K | ﹤0.01% |
39,940
-9,063
| -18% | -$161K |
|
2412
iShares Core S&P Small-Cap ETF
IJR
$111B
| $740K | ﹤0.01% |
12,548
-68,822
| -85% | -$4.07M |
|
2413
Teekay Tankers
TNK
$2.89B
| $740K | ﹤0.01% |
13,999
-2,028
| -13% | -$109K |
|
2414
CALL
Cytokinetics
CYTK
$11B
| $739K | ﹤0.01% |
+110,000
| New | +$721K |
|
2415
PUT
Crocs
CROX
$5.93B
| $736K | ﹤0.01% |
+50,000
| New | +$707K |
|
2416
McCormick & Company Non-Voting
MKC
$14.8B
| $736K | ﹤0.01% |
18,174
-130,596
| -88% | -$5.08M |
|
|
RTK
2417
DELISTED
Rentech, Inc.
RTK
| $735K | ﹤0.01% |
68,668
-3,905
| -5% | -$44.7K |
|
2418
Greenlight Captial
GLRE
$503M
| $734K | ﹤0.01% |
+25,156
| New | +$768K |
|
2419
Corcept Therapeutics
CORT
$13B
| $733K | ﹤0.01% |
121,986
+96,241
| +374% | +$590K |
|
2420
OneSpan
OSPN
$566M
| $733K | ﹤0.01% |
24,283
-58,051
| -71% | -$1.58M |
|
|
IMPV
2421
DELISTED
Imperva, Inc.
IMPV
| $732K | ﹤0.01% |
10,813
-713,178
| -99% | -$39.4M |
|
|
MTSC
2422
DELISTED
MTS Systems Corp
MTSC
| $732K | ﹤0.01% |
+10,619
| New | +$749K |
|
|
EMWP
2423
DELISTED
Eros Media World PLC
EMWP
| $731K | ﹤0.01% |
+1,454
| New | +$566K |
|
2424
Enterprise Financial Services Corp
EFSC
$2.29B
| $730K | ﹤0.01% |
32,069
-7,911
| -20% | -$169K |
|
|
SWIR
2425
DELISTED
Sierra Wireless
SWIR
| $728K | ﹤0.01% |
+29,265
| New | +$946K |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.